Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Q Eichacker

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Critical Care Medicine|October 11, 2005
Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trialPeter Q Eichacker, Robert L Danner, Anthony F Suffredini, et al.
Critical Care Medicine|February 6, 2004
Should we continue to target the platelet-activating factor pathway in septic patients?Peter C Minneci, Katherine J Deans, Steven M Banks, et al.
Critical Care Medicine|August 2, 2019
Antibiotic- and Fluid-Focused Bundles Potentially Improve Sepsis Management, but High-Quality Evidence Is Lacking for the Specificity Required in the Centers for Medicare and Medicaid Service's Sepsis Bundle (SEP-1)Dominique J Pepper, Junfeng Sun, Xizhong Cui, et al.
Anesthesia and Analgesia|October 13, 2009
Practice misalignments in randomized controlled trials: Identification, impact, and potential solutionsKatherine J Deans, Peter C Minneci, Robert L Danner, et al.
Annals of Internal Medicine|November 3, 2004
Corticosteroids for septic shockPeter C Minneci, Katherine J Deans, Steven M Banks, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 16, 2013
B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring modelYan Li, Xizhong Cui, Steven B Solomon, et al.
Annals of Internal Medicine|July 9, 2004
Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dosePeter C Minneci, Katherine J Deans, Steven M Banks, et al.
Critical Care Medicine|December 16, 2004
Substantiating the concerns about recombinant human activated protein C use in sepsisKatherine J Deans, Peter C Minneci, Steven M Banks, et al.
Annals of Internal Medicine|February 21, 2018
Evidence Underpinning the Centers for Medicare & Medicaid Services' Severe Sepsis and Septic Shock Management Bundle (SEP-1): A Systematic ReviewDominique J Pepper, Dharmvir Jaswal, Junfeng Sun, et al.
Toxins|November 10, 2011
The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shockCaitlin W Hicks, Xizhong Cui, Daniel A Sweeney, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Critical Care Medicine|October 11, 2005
Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trialPeter Q Eichacker, Robert L Danner, Anthony F Suffredini, et al.
Critical Care Medicine|February 6, 2004
Should we continue to target the platelet-activating factor pathway in septic patients?Peter C Minneci, Katherine J Deans, Steven M Banks, et al.
Critical Care Medicine|August 2, 2019
Antibiotic- and Fluid-Focused Bundles Potentially Improve Sepsis Management, but High-Quality Evidence Is Lacking for the Specificity Required in the Centers for Medicare and Medicaid Service's Sepsis Bundle (SEP-1)Dominique J Pepper, Junfeng Sun, Xizhong Cui, et al.
Anesthesia and Analgesia|October 13, 2009
Practice misalignments in randomized controlled trials: Identification, impact, and potential solutionsKatherine J Deans, Peter C Minneci, Robert L Danner, et al.
Annals of Internal Medicine|November 3, 2004
Corticosteroids for septic shockPeter C Minneci, Katherine J Deans, Steven M Banks, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 16, 2013
B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring modelYan Li, Xizhong Cui, Steven B Solomon, et al.
Annals of Internal Medicine|July 9, 2004
Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dosePeter C Minneci, Katherine J Deans, Steven M Banks, et al.
Critical Care Medicine|December 16, 2004
Substantiating the concerns about recombinant human activated protein C use in sepsisKatherine J Deans, Peter C Minneci, Steven M Banks, et al.
Annals of Internal Medicine|February 21, 2018
Evidence Underpinning the Centers for Medicare & Medicaid Services' Severe Sepsis and Septic Shock Management Bundle (SEP-1): A Systematic ReviewDominique J Pepper, Dharmvir Jaswal, Junfeng Sun, et al.
Toxins|November 10, 2011
The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shockCaitlin W Hicks, Xizhong Cui, Daniel A Sweeney, et al.
Pageof 13